Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Bellmunt
Joaquim
J
Ribas
Antoni
A
D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016233:Immunotherapy, Active / Q000009:adverse effects / Q000379:methods*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D008297:Male; D009367:Neoplasm Staging; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
D019496:Cancer Vaccines